SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-014195
Filing Date
2017-03-13
Accepted
2017-03-13 14:48:25
Documents
3
Period of Report
2017-03-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v461686_8k.htm 8-K 20402
2 EXHIBIT 99.1 v461686_ex99-1.htm EX-99.1 31781
3 GRAPHIC image_001.jpg GRAPHIC 37958
  Complete submission text file 0001144204-17-014195.txt   105392
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15070 | Film No.: 17684935
SIC: 2834 Pharmaceutical Preparations